Related Experiment Video

Updated: Oct 18, 2026

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Allogeneic hematopoietic stem cell transplantation for acute leukemia, chronic leukemia, and myelodysplasia

L Popplewell¹, S J Forman

¹Department of Hematology, City of Hope National Medical Center, Duarte, California, USA.

Hematology/Oncology Clinics of North America

|November 30, 1999

Abstract:

More than 20,000 patients have survived 5 or more years after allogeneic transplantation, and the number of allogeneic transplantations performed each year continues to increase rapidly. The indications for allogeneic bone marrow transplantation are beginning to change as research continues on the use of transplantation to treat genetic diseases. This article focuses on the use of allogeneic bone marrow transplantation for the treatment of hematologic malignancies, including acute myelogenous leukemia, chronic myelogenous leukemia, acute lymphoblastic leukemia, myelodysplastic syndrome, and chronic lymphocytic leukemia.

More Related Videos

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Related Concept Videos

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Articles linked to this work by shared authors, journal, and citation graph.

Autologous stem-cell transplantation after second-line brentuximab vedotin in relapsed or refractory Hodgkin lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors.

Leukemia·2016

Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation.

Bone marrow transplantation·2014

Efficient selection of genetically modified human T cells using methotrexate-resistant human dihydrofolate reductase.

Gene therapy·2013

Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies.

Leukemia·2012

A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant.

Bone marrow transplantation·2012

See all related articles